Third Rock Ventures Launches $770 Million Biotech Fund

As investor interest in early stage life science companies continues to grow, Third Rock has announced the closing of an oversubscribed fund focused on discovering, launching and building innovative life science companies. This is the company's fifth fund and it has raised $2.7 billion since its inception in 2007.